For: | Li L, Huang YH, Li Y, Wang FQ, Shang BY, Zhen YS. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma. World J Gastroenterol 2005; 11(29): 4478-4483 [PMID: 16052675 DOI: 10.3748/wjg.v11.i29.4478] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i29/4478.htm |
Number | Citing Articles |
1 |
Yanqing Wen, Shuzhen Chen, Zhiyun Meng, Hui Gan, Xiaoxia Zhu, Zhuona Wu, Ruolan Gu, GuiFang Dou. Simultaneous determination of lidamycin enediyne chromophore (LDC) and its aromatized derivative (LDCA) using puerarin as internal standard in rat plasma by LC‐MS/MS. Biomedical Chromatography 2012; 26(3): 400 doi: 10.1002/bmc.1676
|
2 |
Genshen Zhong, Shenghua Zhang, Yi Li, Xiujun Liu, Ruijuan Gao, Qingfang Miao, Yongsu Zhen. A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice. Cancer Letters 2010; 295(1): 124 doi: 10.1016/j.canlet.2010.02.020
|
3 |
Lei Hu, ShengHua Zhang, RongGuang Shao, YongSu Zhen. Lidamycin inhibits tumor growth and pulmonary metastasis in murine breast carcinoma and shows synergy with paclitaxel. Chinese Science Bulletin 2013; 58(23): 2805 doi: 10.1007/s11434-013-5732-3
|
4 |
Ruijuan Gao, Liang Li, Boyang Shang, Chunyan Zhao, Weijin Sheng, Diandong Li. A Gelatinases‐targeting scFv‐based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma. Basic & Clinical Pharmacology & Toxicology 2015; 117(2): 105 doi: 10.1111/bcpt.12379
|
5 |
Ajeeth Adhikari, Christiana N. Teijaro, Craig A. Townsend, Ben Shen. Comprehensive Natural Products III. 2020; : 365 doi: 10.1016/B978-0-12-409547-2.14651-7
|
6 |
Ziqiang Liu, Jiacheng Lai, Heng Jiang, Chengyuan Ma, Haiyan Huang. Collagen XI alpha 1 chain, a potential therapeutic target for cancer. The FASEB Journal 2021; 35(6) doi: 10.1096/fj.202100054RR
|
7 |
Yong-Hong Huang, Yun-Fei Cao, Zhi-Yuan Jiang, Sen Zhang, Feng Gao. Th22 cell accumulation is associated with colorectal cancer development. World Journal of Gastroenterology 2015; 21(14): 4216-4224 doi: 10.3748/wjg.v21.i14.4216
|
8 |
Mulan Wei, Xujie Liu, Chunyu Cao, Jianlin Yang, Yafeng Lv, Jiaojiao Huang, Yanlin Wang, Ye Qin. An engineered PD-1-based and MMP-2/9-oriented fusion protein exerts potent antitumor effects against melanoma. BMB Reports 2018; 51(11): 572 doi: 10.5483/BMBRep.2018.51.11.076
|
9 |
Ajeeth Adhikari, Ben Shen, Christoph Rader. Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates. Antibody Therapeutics 2021; 4(1): 1 doi: 10.1093/abt/tbab001
|
10 |
Qing-fang Miao, Xiao-yun Liu, Bo-yang Shang, Zhi-gang Ouyang, Yong-su Zhen. An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity. Anti-Cancer Drugs 2007; 18(2): 127 doi: 10.1097/CAD.0b013e3280112779
|
11 |
QingFang Miao, BoYang Shang, ZhiGang Ouyang, XiaoYun Liu, YongSu Zhen. Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin. Science in China Series C: Life Sciences 2007; 50(4): 447 doi: 10.1007/s11427-007-0058-5
|
12 |
DENG KONG, XIAOKE WANG, XIAOHONG WANG, XUEYUN WANG, XIAOLI CHEN, GUOQIANG JI, XINHUA FU, SHOUXUN WANG. Design, expression and characterization of single chain Fv, Mms13 and the single chain Fv-mms13 fusion protein. Molecular Medicine Reports 2015; 12(1): 1213 doi: 10.3892/mmr.2015.3561
|
13 |
Rong-guang Shao, Yong-su Zhen. Recent Advances in Cancer Research and Therapy. 2012; : 153 doi: 10.1016/B978-0-12-397833-2.00007-8
|
14 |
Bowen Liu, Jun Liu, Yang Qiu, Jiao Chen, Jing Yang. MITA Promotes Macrophage Proinflammatory Polarization and Its circRNA-Related Regulatory Mechanism in Recurrent Miscarriage. International Journal of Molecular Sciences 2023; 24(11): 9545 doi: 10.3390/ijms24119545
|